Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Continuous Veno-venous Hemodiafiltration on Efficacy of Administration of Prophylactic Doses of Enoxaparin or Fondaparinux in Critically Ill Patients.

NCT04671160 is registered in ClinicalTrials.gov with Medical University of Gdansk as lead sponsor.

NCT NCT04671160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04671160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Continuous Veno-venous Hemodiafiltration on Efficacy of Administration of Prophylactic Doses of Enoxaparin or Fondaparinux in Critically Ill Patients.
Lead sponsor
Medical University of Gdansk
Phase
Observational
Overall status
Unknown status
Start date
January 4, 2021
Completion date
September 30, 2022
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

assessment of activity of anti-xa factor in patients treated with continuous veno-venous hemodiafiltration receiving anticoagulant prophylaxis